Copper Regulates the Canonical NLRP3 Inflammasome

Area of Science:

• Immunology
• Molecular Biology
• Pathology

Background:

• Inflammasomes, particularly NLRP3, are critical protein complexes regulating inflammatory responses.
• NLRP3 inflammasome activation is implicated in diverse human pathologies but its precise mechanisms remain unclear.
• Understanding NLRP3 activation is crucial for developing targeted anti-inflammatory therapies.

Purpose of the Study:

• To investigate the role of intracellular copper in NLRP3 inflammasome activation.
• To evaluate the therapeutic potential of targeting intracellular copper homeostasis for NLRP3-dependent diseases.

Main Methods:

• Utilized copper chelators, including tetrathiomolybdate, to assess effects on inflammasome activation.
• Examined the impact of copper removal from superoxide dismutase 1 on inflammasome function.
• Investigated NLRP3 inflammasome regulation in macrophages and monocytes from mice and humans.
• Assessed in vivo effects of copper depletion on inflammation and endotoxic shock.

Main Results:

• NLRP3 inflammasome activation specifically requires intracellular copper.
• Copper depletion using tetrathiomolybdate inhibited NLRP3 but not other inflammasomes (AIM2, NLRC4, NLRP1) or NF-κB priming.
• Removing copper from superoxide dismutase 1 impaired NLRP3 inflammasome function.
• Copper regulation of NLRP3 inflammasome is specific to macrophages.
• In vivo copper depletion attenuated caspase-1-dependent inflammation and reduced susceptibility to LPS-induced endotoxic shock.

Conclusions:

• Intracellular copper is a critical regulator of NLRP3 inflammasome activation.
• Targeting intracellular copper homeostasis presents a promising therapeutic avenue for NLRP3-dependent inflammatory diseases.
• Copper chelation offers a specific strategy to modulate NLRP3 inflammasome activity.